GW-501516, also known as Cardarine, is a research compound classified as a PPARδ agonist, not a SARM. It activates the PPARδ pathway, which plays a central role in regulating fatty acid oxidation, glucose metabolism, and mitochondrial biogenesis. This makes it a compound of interest in studies focusing on enhanced endurance, improved lipid profiles, and efficient energy utilization.

Research has shown that GW-501516 may increase the expression of genes involved in energy expenditure, making it relevant in studies of obesity, insulin sensitivity, and metabolic syndrome. Additionally, its ability to improve stamina and reduce recovery times has led to its inclusion in research on physical performance and fatigue resistance. Importantly, Cardarine does not exhibit anabolic or androgenic activity, which differentiates it from SARMs and makes it suitable for metabolic-focused investigations.